{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:52:26Z","timestamp":1793875946273,"version":"4.7.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A precondition for developing strategies to reduce polypharmacy and its well-known harmful consequences is to study its epidemiology and associated factors. The objective of this study was to analyse the prevalence of polypharmacy (defined as \u22658 prescribed drugs), of potentially inappropriate medications (PIMs) and major drug-drug interactions (DDIs) among community-dwelling general practice patients aged \u226575\u2009years and to identify characteristics being associated with polypharmacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study is derived from baseline data (patients\u2019 demographic\/biometric characteristics, diagnoses, medication-related data, cognitive\/affective status, quality of life) of a northern-Italian cluster-RCT. PIMs and DDIs were assessed using the 2012 Beers criteria and the Lexi-Interact\u00ae database. Data were analysed using descriptive methods, Wilcoxon rank-sum tests, Fisher\u2019s exact tests and Spearman correlations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the eligible patients aged 75+, 13.4% were on therapy with \u22658 drugs. Forty-three general practitioners and 579 patients participated in the study. Forty five point nine percent of patients were treated with \u22651 Beers-listed drugs. The most frequent PIMs were benzodiazepines\/hypnotics (19.7% of patients) and NSAIDs (6.6%). Sixty seven point five percent of patients were exposed to \u22651 major DDI, 35.2% to \u22652 major DDIs. Antithrombotic\/anticoagulant medications (30.4%) and antidepressants\/antipsychotics (23.1%) were the most frequently interacting drugs. Polypharmacy was significantly associated with a higher number of major DDIs (Spearman\u2019s rho 0.33,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and chronic conditions (Spearman\u2019s rho 0.20,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), higher 5-GDS scores (thus, lower affective status) (Spearman\u2019s rho 0.12,<jats:italic>p<\/jats:italic>\u2009=\u20090.003) and lower EQ-5D-5L scores (thus, lower quality of life) (Spearman\u2019s rho \u2212\u20090.14,<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Patients\u2019 age\/sex, 6-CIT scores (cognitive status), BMI or PIM use were not correlated with the number of drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of polypharmacy, PIMs and major DDIs was considerable. Results indicate that physicians should particularly observe their patients with multiple conditions, reduced health and affective status, independently from other patients\u2019 characteristics. Careful attention about indication, benefit and potential risk should be paid especially to patients on therapy with specific drug classes identified as potentially inappropriate or prone to major DDIs in older persons (e.g., benzodiazepines, NSAIDs, protonic pump inhibitors, antithrombotics\/anticoagulants, antidepressants\/antipsychotics).<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>The cluster-RCT on which this cross-sectional analysis is based was registered with Current Controlled Trials Ltd. (ID<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN38449870?q=ISRCTN38449870&amp;filters=&amp;sort=&amp;offset=1&amp;totalResults=1&amp;page=1&amp;pageSize=10&amp;searchType=basic-search\">ISRCTN: 38449870<\/jats:ext-link>) on 2013-09-11.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12877-021-02141-w","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T19:02:31Z","timestamp":1616266951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Giuliano","family":"Piccoliori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5280-5447","authenticated-orcid":false,"given":"Angelika","family":"Mahlknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"V\u00f6gele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Deflorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolf","family":"Engl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"S\u00f6nnichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wiedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"2141_CR1","volume-title":"Clinical guidelines for chronic conditions in the European Union","author":"HPD Legido-Quigley","year":"2013","unstructured":"Legido-Quigley HPD, Car J, McKee M, Busse R. Clinical guidelines for chronic conditions in the European Union. Geneva: World Health Organization; 2013."},{"issue":"7","key":"2141_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2105\/AJPH.2007.121137","volume":"98","author":"A Marengoni","year":"2008","unstructured":"Marengoni A, Winblad B, Karp A, Fratiglioni L. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health. 2008;98(7):1198\u2013200.","journal-title":"Am J Public Health"},{"issue":"3","key":"2141_CR3","first-page":"12","volume":"6","author":"ESF Tragni","year":"2014","unstructured":"Tragni ESF, Casula M. Elders with multiple chronic conditions: epidemiology and drug use. G Ital Farmacoecon Farmacoutilizzazione. 2014;6(3):12.","journal-title":"G Ital Farmacoecon Farmacoutilizzazione"},{"issue":"1","key":"2141_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"2141_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.293.11.1348","volume":"293","author":"D Fialov\u00e1","year":"2005","unstructured":"Fialov\u00e1 D, Topinkov\u00e1 E, Gambassi G, Finne-Soveri H, J\u00f3nsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348\u201358.","journal-title":"JAMA."},{"issue":"1","key":"2141_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12877-019-1263-3","volume":"19","author":"A Mahlknecht","year":"2019","unstructured":"Mahlknecht A, Krisch L, Nestler N, Bauer U, Letz N, Zenz D, et al. Impact of training and structured medication review on medication appropriateness and patient-related outcomes in nursing homes: results from the interventional study InTherAKT. BMC Geriatr. 2019;19(1):257.","journal-title":"BMC Geriatr"},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Midao","year":"2018","unstructured":"Midao L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213\u201320.","journal-title":"Arch Gerontol Geriatr"},{"issue":"31-32","key":"2141_CR8","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31-32):543\u201351.","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"2141_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11739-018-1941-8","volume":"13","author":"PM Mannucci","year":"2018","unstructured":"Mannucci PM, Nobili A, Pasina L, Collaborators R. Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register. Intern Emerg Med. 2018;13(8):1191\u2013200.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2141_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1345\/aph.1D313","volume":"38","author":"JT Hanlon","year":"2004","unstructured":"Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9\u201314.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"2141_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/gerona\/glt118","volume":"69","author":"G Onder","year":"2014","unstructured":"Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, et al. High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci. 2014;69(4):430\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2141_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.archger.2018.05.007","volume":"77","author":"P Fabbietti","year":"2018","unstructured":"Fabbietti P, Ruggiero C, Sganga F, Fusco S, Mammarella F, Barbini N, et al. Effects of hyperpolypharmacy and potentially inappropriate medications (PIMs) on functional decline in older patients discharged from acute care hospitals. Arch Gerontol Geriatr. 2018;77:158\u201362.","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"2141_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12603-014-0029-z","volume":"18","author":"F Sganga","year":"2014","unstructured":"Sganga F, Vetrano DL, Volpato S, Cherubini A, Ruggiero C, Corsonello A, et al. Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study. J Nutr Health Aging. 2014;18(6):616\u201321.","journal-title":"J Nutr Health Aging"},{"issue":"7456","key":"2141_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ."},{"issue":"8","key":"2141_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s40520-017-0856-y","volume":"30","author":"P Fabbietti","year":"2018","unstructured":"Fabbietti P, Di Stefano G, Moresi R, Cassetta L, Di Rosa M, Fimognari F, et al. Impact of potentially inappropriate medications and polypharmacy on 3-month readmission among older patients discharged from acute care hospital: a prospective study. Aging Clin Exp Res. 2018;30(8):977\u201384.","journal-title":"Aging Clin Exp Res"},{"key":"2141_CR16","volume-title":"Population structure and ageing","author":"Eurostat","year":"2016","unstructured":"Eurostat. Population structure and ageing. 2016. http:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php\/Population_structure_and_ageing#Further_Eurostat_information. Accessed 5 Feb 2021."},{"key":"2141_CR17","volume-title":"National Population Projections: 2014-based statistical bulletin","author":"Office for National Statistics","year":"2015","unstructured":"Office for National Statistics. National Population Projections: 2014-based statistical bulletin. London: Office for National Statistics; 2015."},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13063-016-1177-8","volume":"17","author":"A Sonnichsen","year":"2016","unstructured":"Sonnichsen A, Trampisch US, Rieckert A, Piccoliori G, Vogele A, Flamm M, et al. Polypharmacy in chronic diseases-reduction of inappropriate medication and adverse drug events in older populations by electronic decision support (PRIMA-eDS): study protocol for a randomized controlled trial. Trials. 2016;17:57.","journal-title":"Trials."},{"issue":"1","key":"2141_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12875-018-0795-5","volume":"19","author":"A Rieckert","year":"2018","unstructured":"Rieckert A, Trampisch US, Klaassen-Mielke R, Drewelow E, Esmail A, Johansson T, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19(1):113.","journal-title":"BMC Fam Pract"},{"issue":"6","key":"2141_CR20","first-page":"430","volume":"9","author":"D Garfinkel","year":"2007","unstructured":"Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430\u20134.","journal-title":"Isr Med Assoc J"},{"issue":"10","key":"2141_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"11","key":"2141_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.0.CO;2-1","volume":"14","author":"P Brooke","year":"1999","unstructured":"Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14(11):936\u201340.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"2141_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1034\/j.1600-0579.2003.00216.x","volume":"51","author":"P Rinaldi","year":"2003","unstructured":"Rinaldi P, Mecocci P, Benedetti C, Ercolani S, Bregnocchi M, Menculini G, et al. Validation of the five-item geriatric depression scale in elderly subjects in three different settings. J Am Geriatr Soc. 2003;51(5):694\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2141_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert P","year":"2012","unstructured":"American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"2141_CR25","volume-title":"Appropriatezza prescrittiva nella popolazione anziana - Elenco farmaci potenzialmente inappropriati ed eventuali alternative terapeutiche","author":"Servizio Sanitario Regionale Emilia-Romagna","year":"2014","unstructured":"Servizio Sanitario Regionale Emilia-Romagna. Appropriatezza prescrittiva nella popolazione anziana - Elenco farmaci potenzialmente inappropriati ed eventuali alternative terapeutiche. Parma: Servizio Sanitario Regionale Emilia-Romagna; 2014."},{"key":"2141_CR26","unstructured":"UpToDate\u00ae Drugs & drug interaction database. 2016. https:\/\/www.uptodate.com\/home\/uptodate-drug-interactions-tool. Accessed 6 Mar 2020."},{"key":"2141_CR27","volume-title":"EQ-5D-5L valuation crosswalk index value calculator","author":"EuroQoL","year":"2014","unstructured":"EuroQoL. EQ-5D-5L valuation crosswalk index value calculator. 2014. https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/valuation-standard-value-sets\/crosswalk-index-value-calculator\/. Accessed 22 Sept 2014."},{"key":"2141_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7596-1","volume-title":"Self-reported population health: an international perspective based on EQ-5D","author":"A Szende","year":"2014","unstructured":"Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. 2014. https:\/\/eq-5dpublications.euroqol.org\/download?id=0_54006&fileId=54415. Accessed 2 Apr 2019."},{"key":"2141_CR29","unstructured":"EuroQol Research Foundation. EQ-5D-5L user guide. 2019. https:\/\/euroqol.org\/publications\/user-guides\/. Accessed 10 June\u00a02020."},{"issue":"2","key":"2141_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/biom.12812","volume":"74","author":"Q Liu","year":"2018","unstructured":"Liu Q, Li C, Wanga V, Shepherd BE. Covariate-adjusted Spearman\u2019s rank correlation with probability-scale residuals. Biometrics. 2018;74(2):595\u2013605.","journal-title":"Biometrics."},{"issue":"3","key":"2141_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/fampra\/cms070","volume":"30","author":"D Koper","year":"2013","unstructured":"Koper D, Kamenski G, Flamm M, Bohmdorfer B, Sonnichsen A. Frequency of medication errors in primary care patients with polypharmacy. Fam Pract. 2013;30(3):313\u20139.","journal-title":"Fam Pract"},{"key":"2141_CR32","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2147\/PPA.S219346","volume":"13","author":"PA Simoes","year":"2019","unstructured":"Simoes PA, Santiago LM, Mauricio K, Simoes JA. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: a Nationwide cross-sectional study. Patient Prefer Adherence. 2019;13:1569\u201376.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"2141_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12875-018-0825-3","volume":"19","author":"F von Buedingen","year":"2018","unstructured":"von Buedingen F, Hammer MS, Meid AD, Muller WE, Gerlach FM, Muth C. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice. BMC Fam Pract. 2018;19(1):131.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"2141_CR34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4081\/jphr.2016.745","volume":"5","author":"L Arnoldo","year":"2016","unstructured":"Arnoldo L, Cattani G, Cojutti P, Pea F, Brusaferro S. Monitoring Polypharmacy in healthcare systems through a multi-setting survey: should we put more attention on long term care facilities? J Public Health Res. 2016;5(3):745.","journal-title":"J Public Health Res"},{"key":"2141_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/CLEP.S153458","volume":"10","author":"L Morin","year":"2018","unstructured":"Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289\u201398.","journal-title":"Clin Epidemiol"},{"key":"2141_CR36","first-page":"24","volume":"16","author":"M Arcopinto","year":"2017","unstructured":"Arcopinto M, Cataldi M, De Luca V, Orlando V, Simeone G, D'Assante R, et al. Implementing an ICT-based Polypharmacy management program in Italy. Transl Med UniSa. 2017;16:24\u20139.","journal-title":"Transl Med UniSa"},{"issue":"23-24","key":"2141_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00508-008-1089-z","volume":"120","author":"J Schuler","year":"2008","unstructured":"Schuler J, Duckelmann C, Beindl W, Prinz E, Michalski T, Pichler M. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr. 2008;120(23-24):733\u201341.","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"2141_CR38","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/bcp.12754","volume":"80","author":"E Raschi","year":"2015","unstructured":"Raschi E, Piccinni C, Signoretta V, Lionello L, Bonezzi S, Delfino M, et al. Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice. Br J Clin Pharmacol. 2015;80(6):1411\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2141_CR39","doi-asserted-by":"publisher","first-page":"e0189599","DOI":"10.1371\/journal.pone.0189599","volume":"13","author":"M Bucholc","year":"2018","unstructured":"Bucholc M, O'Kane M, Ashe S, Wong-Lin K. Prescriptive variability of drugs by general practitioners. PLoS One. 2018;13(2):e0189599.","journal-title":"PLoS One"},{"issue":"12","key":"2141_CR40","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2165\/11584990-000000000-00000","volume":"27","author":"SL Slabaugh","year":"2010","unstructured":"Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019\u201328.","journal-title":"Drugs Aging"},{"key":"2141_CR41","volume-title":"Choice of drug therapy in primary (essential) hypertension","author":"J Mann","year":"2020","unstructured":"Mann J. Choice of drug therapy in primary (essential) hypertension. 2020. https:\/\/www.uptodate.com\/contents\/choice-of-drug-therapy-in-primary-essential-hypertension?search=indication%20ARBs%20hypertension&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 13 Nov 2020."},{"issue":"7","key":"2141_CR42","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/jgs.14870","volume":"65","author":"SE Merel","year":"2017","unstructured":"Merel SE, Paauw DS. Common drug side effects and drug-drug interactions in elderly adults in primary care. J Am Geriatr Soc. 2017;65(7):1578\u201385.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2141_CR43","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473\u201382.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"2141_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejim.2011.08.029","volume":"22","author":"A Nobili","year":"2011","unstructured":"Nobili A, Marengoni A, Tettamanti M, Salerno F, Pasina L, Franchi C, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med. 2011;22(6):597\u2013602.","journal-title":"Eur J Intern Med"},{"key":"2141_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2318-11-79","volume":"11","author":"L Guaraldo","year":"2011","unstructured":"Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr. 2011;11:79.","journal-title":"BMC Geriatr"},{"issue":"11","key":"2141_CR46","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2015","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"2141_CR47","unstructured":"Italian Medicines Agency AIFA (Agenzia Italiana dei Farmaci). 2019. http:\/\/www.agenziafarmaco.gov.it\/content\/nota-1. Accessed 13 Jan 2021."},{"issue":"6","key":"2141_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12603-015-0642-5","volume":"20","author":"R Schepisi","year":"2016","unstructured":"Schepisi R, Fusco S, Sganga F, Falcone B, Vetrano DL, Abbatecola A, et al. Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals. J Nutr Health Aging. 2016;20(6):665\u201370.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"2141_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00228-018-2555-9","volume":"75","author":"V Weiss","year":"2019","unstructured":"Weiss V, Nau R, Glaeske G, Hummers E, Himmel W. The interplay of context factors in hypnotic and sedative prescription in primary and secondary care-a qualitative study. Eur J Clin Pharmacol. 2019;75(1):87\u201397.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2141_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/13607860410001669778","volume":"8","author":"S Iliffe","year":"2004","unstructured":"Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8(3):242\u20138.","journal-title":"Aging Ment Health"},{"issue":"3","key":"2141_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jamda.2016.11.025","volume":"18","author":"DC Muhlack","year":"2017","unstructured":"Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Sch\u00f6ttker B. The Association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J Am Med Dir Assoc. 2017;18(3):211\u201320.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"2141_CR52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/pds.3510","volume":"22","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Nobili A, Tettamanti M, Franchi C, Salerno F, et al. Drug-drug interactions in a cohort of hospitalized elderly patients. Pharmacoepidemiol Drug Saf. 2013;22(10):1054\u201360.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2141_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/fampra\/cml067","volume":"24","author":"U Junius-Walker","year":"2007","unstructured":"Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24(1):14\u20139.","journal-title":"Fam Pract"},{"issue":"6","key":"2141_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","volume":"26","author":"J Jyrkka","year":"2009","unstructured":"Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493\u2013503.","journal-title":"Drugs Aging"},{"key":"2141_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13:74.","journal-title":"BMC Med"},{"issue":"4","key":"2141_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00228-013-1621-6","volume":"70","author":"C Franchi","year":"2014","unstructured":"Franchi C, Tettamanti M, Pasina L, Djignefa CD, Fortino I, Bortolotti A, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. Eur J Clin Pharmacol. 2014;70(4):437\u201343.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2141_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1574886311308020002","volume":"8","author":"M Tosato","year":"2013","unstructured":"Tosato M, Settanni S, Antocicco M, Battaglia M, Corsonello A, Ruggiero C, et al. Pattern of medication use among older inpatients in seven hospitals in Italy: results from the CRiteria to assess appropriate medication use among elderly complex patients (CRIME) project. Curr Drug Saf. 2013;8(2):98\u2013103.","journal-title":"Curr Drug Saf"},{"issue":"6","key":"2141_CR58","doi-asserted-by":"publisher","first-page":"e98043","DOI":"10.1371\/journal.pone.0098043","volume":"9","author":"HA Kim","year":"2014","unstructured":"Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PLoS One. 2014;9(6):e98043.","journal-title":"PLoS One"},{"issue":"12","key":"2141_CR59","doi-asserted-by":"publisher","first-page":"e0226511","DOI":"10.1371\/journal.pone.0226511","volume":"14","author":"S Toepfer","year":"2019","unstructured":"Toepfer S, Bolbrinker J, Konig M, Steinhagen-Thiessen E, Kreutz R, Demuth I. Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - sex differences and associations with morbidity and medication use. PLoS One. 2019;14(12):e0226511.","journal-title":"PLoS One"},{"issue":"5","key":"2141_CR60","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1590\/1413-81232018245.16032017","volume":"24","author":"C Iniesta-Navalon","year":"2019","unstructured":"Iniesta-Navalon C, Gascon-Canovas JJ, Gama Z, Sanchez-Ruiz JF, Gutierrez-Estrada EA, De-la-Cruz-Sanchez E, et al. Potential and clinical relevant drug-drug interactions among elderly from nursing homes: a multicentre study in Murcia, Spain. Cien Saude Colet. 2019;24(5):1895\u2013902.","journal-title":"Cien Saude Colet"},{"issue":"Suppl 1","key":"2141_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/11534640-000000000-00000","volume":"26","author":"A Corsonello","year":"2009","unstructured":"Corsonello A, Pranno L, Garasto S, Fabietti P, Bustacchini S, Lattanzio F. Potentially inappropriate medication in elderly hospitalized patients. Drugs Aging. 2009;26(Suppl 1):31\u20139.","journal-title":"Drugs Aging"},{"issue":"9582","key":"2141_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","volume":"370","author":"A Spinewine","year":"2007","unstructured":"Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173\u201384.","journal-title":"Lancet."},{"issue":"Suppl 1","key":"2141_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF03319100","volume":"35","author":"A Corsonello","year":"2012","unstructured":"Corsonello A, Onder G, Abbatecola AM, Guffanti EE, Gareri P, Lattanzio F. Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from beers to STOPP\/START criteria. Drug Saf. 2012;35(Suppl 1):21\u20138.","journal-title":"Drug Saf"},{"issue":"9","key":"2141_CR64","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/11538240-000000000-00000","volume":"27","author":"C Ruggiero","year":"2010","unstructured":"Ruggiero C, Dell'Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747\u201358.","journal-title":"Drugs Aging"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02141-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12877-021-02141-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02141-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T16:00:04Z","timestamp":1698076804000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-021-02141-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1186\/s12877-021-02141-w","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and with Italian data protection regulations. Written informed consent was obtained from all participating GPs and patients prior to their inclusion.The cluster-randomised controlled trial from which this cross-sectional analysis is derived was registered with Current Controlled Trials Ltd. (ID ISRCTN: 38449870) on 2013-09-11. Ethical approval was obtained from the responsible Ethics Committee of Bolzano on 2013-05-15, approval number: 42-2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}